<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00773760</url>
  </required_header>
  <id_info>
    <org_study_id>ITK-1</org_study_id>
    <nct_id>NCT00773760</nct_id>
  </id_info>
  <brief_title>MOR and COMT SNP Polymorphism and Pain</brief_title>
  <official_title>Does mu Opioid Receptor (MOR) and Catechol-O-methyltransferase (COMT) Genes Polymorphism Correlate of Clinical Postoperative Pain and Response to Analgesics</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>East Tallinn Central Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>East Tallinn Central Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with certain polymorphism in the MOR and COMT genes will display differences in
      their response to analgesics.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After tissue injury, there is great interindividual variability among patients in the amount
      of pain experienced (pain intensity and duration of pain) and in the degree of pain relief
      from analgesics. In experimental settings, Single Nucleotide Polymorphisms (SNP) at the MOR
      and COMT genes have been found to alter the response to opioids in in vitro models and in
      human.We will collect clinical data on one hundred patients undergoing surgery. We will
      obtain DNA extracted via PCR techniques from the patients' blood and we will identify SNPs at
      the mu opioid receptor and catechol-O-methyltransferase genes. We will analyze the data to
      search for correlation between clinical patterns of postoperative pain and opioid effects and
      SNPs.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2008</start_date>
  <completion_date type="Anticipated">December 2009</completion_date>
  <primary_completion_date type="Anticipated">October 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative assessments include PCA use (e.g., number of patient demands, total morphine administered) in each 24-h interval during the 48-h study period - primary endpoint.</measure>
    <time_frame>48 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>No secondary outcome endpoint</measure>
    <time_frame>no time frame</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Pain Relief</condition>
  <arm_group>
    <arm_group_label>dosing</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>SNP genotyping</intervention_name>
    <description>Coded blood specimens will be transported to the Department of Gene Technology TTÃœ and genotyping analysis will be performed. Lymphocytes will be isolated from blood specimens using Ficol-Paq gradients, and genomic DNA isolated using a salting-out procedure. Variants of the MOR gene and other genes of interests will be performed by DNA sequence analysis of PCR-amplified DNA, using primers located in flanking intron sequence. All methods proposed are currently in operation in the respective facilities.</description>
    <arm_group_label>dosing</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        patients with prostate cancer
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years of age and older

          -  Give informed consent to participate in this study

        Exclusion Criteria:

          -  Neurologic or psychiatric disease sufficient, in the clinical judgment of the
             investigator, to compromise informed consent or data collection

          -  ASA classification score 3 or above

          -  Patients with past or present history of substance abuse.

          -  Patients with a history of chronic pain requiring daily analgesic use for more then
             one month.

          -  Patients with a current diagnosis of anxiety or depression requiring medical treatment

          -  Patients allergic to morphine
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yuri Kolesnikov, MD PhD</last_name>
    <role>Study Director</role>
    <affiliation>ETCH</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Yuri Kolesnikov MD PhD</name>
      <address>
        <city>Tallinn</city>
        <zip>11312</zip>
        <country>Estonia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peeter Ross, MD</last_name>
      <phone>372 6973002</phone>
      <email>peeter.ross@itk.ee</email>
    </contact>
    <contact_backup>
      <last_name>Yuri Kolesnikov</last_name>
      <phone>372 6973002</phone>
      <email>yuri.kolesnikov@itk.ee</email>
    </contact_backup>
    <investigator>
      <last_name>Boris Gabovits, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yuri Kolesnikov, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Estonia</country>
  </location_countries>
  <link>
    <url>http://www.itk.ee</url>
    <description>East Tallinn Central Hospital</description>
  </link>
  <verification_date>August 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 15, 2008</study_first_submitted>
  <study_first_submitted_qc>October 15, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 16, 2008</study_first_posted>
  <last_update_submitted>August 4, 2009</last_update_submitted>
  <last_update_submitted_qc>August 4, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 6, 2009</last_update_posted>
  <responsible_party>
    <name_title>A.Veske PhD Director of Department of Gene Technology</name_title>
    <organization>TTU</organization>
  </responsible_party>
  <keyword>opioids</keyword>
  <keyword>COMT</keyword>
  <keyword>SNP</keyword>
  <keyword>analgesia</keyword>
  <keyword>postoperative pain</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

